Prestige Brands' Costs Grow With OTC Portfolio, But Retailer Orders Slow
Executive Summary
Consumer products firm's execs also expect "destocking" by drug, grocery and mass merchandise chains and other retail businesses to give way to increased purchase orders, but analysts say losing market share to e-commerce and higher freight costs could be here to stay.
You may also be interested in...
OTC Evolution For Prestige Brands Combines Near- And Long-Term Strategies
BC, Goody's, Monistat marketer boosts domestic and international OTC revenues immediately with C.B. Fleet acquisition, looks ahead to manufacturing expansion.
Safe Use Of Hydrogen-Peroxide Contact Lens Solution Magnified in US FDA Draft Guidance
Draft guidance pulls from Ophthalmic Devices Panel and Risk Communication Advisory Committee 2017 meeting to discuss more clearly communicating risks of the solutions to consumers while allowing products to remain available OTC.
House Members Object To Senate Adding Supplement MPL Proposal In FDA User Fee Bill
Members led by SC Republican Jeff Duncan and CA Democrat Tony Cárdenas, in letter to House speaker and minority leader, oppose MPL provision in latest version of S.4348 for re-authorizing FDA drug, biologic and medical device user fee programs.